Swipe om te navigeren naar een ander artikel
Department of Sports Medicine, Isala Clinics, Zwolle, the Netherlands
Background. To evaluate the safety and effects of high altitude on exercise level and heart rate in patients with coronary artery disease compared with healthy controls.
Methods. Eight patients with a history of an acute myocardial infarction (ejection fraction >5%) with a low-risk score were compared with seven healthy subjects during the Dutch Heart Expedition at the Aconcagua in Argentina in March 2007. All subjects underwent a maximum exercise test with a cycle ergometer at sea level and base camp, after ten days of acclimatisation, at an altitude of 4200 m. Exercise capacity and maximum heart rate were compared between groups and within subjects.
Results. There was a significant decrease in maximum heart rate at high altitude compared with sea level in both the patient and the control group (166 vs. 139 beats/min, p<0.001 and 181 vs. 150 beats/min, p<0.001). There was no significant difference in the decrease of the exercise level and maximum heart rate between patients and healthy controls (-31 vs. -30%, p=0.673).
Conclusion. Both patients and healthy controls showed a similar decrease in exercise capacity and maximum heart rate at 4200 m compared with sea level, suggesting that patients with a history of coronary artery disease may tolerate stay and exercise at high altitude similarly to healthy controls. (Neth Heart J 2010;18:118-21.)
Log in om toegang te krijgen
Met onderstaand(e) abonnement(en) heeft u direct toegang:
Vona M, Mazzuero G, Lupi A, Vettorato C, Bosso P, Cohen-Solal A. Effects of altitude on effort tolerance in non-acclimatized patients with ischemic left ventricular dysfunction. Eur J Cardiovasc Prev Rehabil. 2006;13:617-24.
Erdman J, Sun KT, Masar P, Niederhauser H. Effects of exposure to altitude on men with coronary artery disease and impaired left ventricular function. Am J Cardiol. 1998;81:266-70.
Agostini P, Catadori G, Guazzi M, Busotti M, Conca C, Lomanto M, et al. Effects of simulated altitude-induced hypoxia on exercise capacity in patients with chronic heart failure. Am J Med. 2000;109:450-5.
Wyss CA, Koepfli P, Fretz G, Seebauer M, Schirlo C, Kaufmann PA. Influence of altitude exposure on coronary flow reserve. Circulation. 2003;108:1202-7.
Schmid JP, Noveanu M, Gaillet R, Hellige G, Wahl A, Saner H. Safety and exercise tolerance of acute high altitude exposure (3454 m) among patients with coronary artery disease. Heart. 2006;92:921-5.
Clark AM, Hartling L, Vandermeer B, McAlister FA. Meta-analysis: secondary prevention programs for patients with coronary artery disease. Ann Intern Med. 2005;143:659-72.
Ades PA. Cardiac rehabilitation and secondary prevention of coronary heart disease. N Engl J Med. 2001;345:892-902.
Wagner PD. Reduced maximal cardiac output at altitude-mechanisms and significance. Respir Physiol Neurobiol. 2000;120:1-11.
Hainsworth R, Drinkhill MJ. Cardiovascular adjustments for life at high altitude. Respir Physiol Neurobiol. 2007;158:204-11.
De Luca G, Suryapranata H, van ’t Hof AWJ, de Boer MJ, Hoorntje JCA, Dambrink JHE, et al. Prognostic assessment of patients with acute myocardial infarction treated with primary angioplasty. Circulation. 2004; 109:2737-43.
Pina IL, Balady GJ, Hanson P, Labovitz AJ, Madonna DW, Myers J. Guidelines for clinical exercise testing laboratories. Circulation. 1995;91:912-21.
Lear SA, Brozic A, Myers JN, Ignazewski A. Exercise stress testing. An overview of current guidelines. Sports Med. 1999;27:285-312.
Hartley LH, Vogel JA, Cruz JC. Reduction of maximal exercise heart rate at altitude and its reversal with atropine. J Appl Physiol. 1974;36:362-5.
Bhaumik G, Dass D, Lame H, Chauchan SK. Maximum exercise responses of men and women mountaineering trainees on induction to high altitude (4350 m) by trekking. Wilderness Environ Med. 2008;19:151-6.
ACSM’s Guidelines for exercise testing and prescription, 7 th edition 2006.
Robergs RA, Landwehr R. The surprising history of the “Hrmax=220-age” equation. J Exerc Physionline. 2002;2:1-10
Boushel R, Calbet JA, Radegran G, Sondergaard H, Wagner PD, Saltin B. Parasympathetic neural activity accounts for the lowering of exercise heart rate at high altitude. Circulation. 2001;104:1785-97.
Schoene RB. Limits of human lung function at high altitude. J Exp Biol. 2001;173:409-17.
Forte VA Jr, Leith DE, Muza SR, Fulco CS, Cymerman A. Ventilatory capacities at sea level and high altitude. Aviat Space Environ Med. 1997;68:488-93.
Calbet JA, Radegran G, Boushel R, Sondergaard H, Saltin B, Wagner PD. Effect of blood haemoglobin concentration on VO2 max and cardiovascular function in lowlanders acclimatised to 5260 m. J Physiol. 2002;545:715-28.
Lundby L, Araoz M, van Hall G. Peak heart rate decreases with increasing severity of acute hypoxia. High Alt Med Biol. 2001;2:369-76.
- Effects of altitude on exercise level and heart rate in patients with coronary artery disease and healthy controls
S. T. de Vries
G. C. van Enst
A. W. J. van ’t Hof
- Bohn Stafleu van Loghum